ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

Antman Is President Elect; Minorities More Likely To Get Worse Care, IOM Finds

April 12, 2002

Funding Opportunities

September 13, 2002

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014